Amgen cans its TScan partnership; Amylyx reveals $350M offering

Plus news about BioArctic, Enveda, Georgiamune, Kynexis, Tolerance Bio and Network Bio. Amgen puts the "can" in TScan: Amgen is terminating its partnership with TScan Therapeutics, the Waltham, MA-based T cell therapy maker said in ...